Search - tctmd.com

Displaying 21 - 40 of 126

Sort: Relevancy | Date

News Industry News

Two-year data shows trend towards lower target vessel failure with Indian stent Supraflex vs. Xience stent from Abbott

October 09, 2019

News Industry News

SMT Announces CE* Mark for the Most Deliverable Stent Supraflex Cruz

July 11, 2019

News Conference News ACC 2019

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

Michael O'Riordan

March 18, 2019

News Daily News

Femoral Operators Get Bad Rap in Observational Studies, HEAT-PPCI Suggests

Michael O'Riordan

January 21, 2019

Presentation ESC 2018

The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX

Presenter: Marco Valgimigli

August 26, 2018

News Conference News ESC 2018

MATRIX: 1-Year Results Confirm Superiority of Transradial PCI

Michael O'Riordan

August 25, 2018

News Features

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

Todd Neale

June 08, 2018

News Conference News CRT 2018

Radial Access PCI Reduces Risk of Mortality and Bleeding in VALIDATE-SWEDEHEART

Michael O'Riordan

March 06, 2018

News Daily News

Higher Bleeding Risks, Radial Advantages Confirmed in Women With ACS Undergoing PCI: MATRIX Subanalysis

Yael L. Maxwell

January 03, 2018

News Conference News AHA 2017

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Michael O'Riordan

November 12, 2017

Presentation TCT 2017

Radial Approach and Renal Protection: A MATRIX Trial Analysis

Presenter: Prashant Kaul, Jennifer A. Tremmel, Marco Valgimigli

October 30, 2017

News Conference News ESC 2017

Latest Bivalirudin, Heparin Face-off in MI Cements Winner in Routine Practice: VALIDATE-SWEDEHEART

Shelley Wood

August 27, 2017

News Features

Valve, Heal Thyself: Pioneers Seek Tissue-Engineered Fix for Faulty, Failing Cardiac Parts

Caitlin E. Cox

June 14, 2017

News Daily News

Large US Study Suggests Little Difference Between Bivalirudin and Heparin for Transradial Primary PCI

Todd Neale

May 22, 2017

News Conference News EuroPCR 2017

Transradial PCI in ACS Reduces Risk of Acute Kidney Injury

Michael O'Riordan

May 18, 2017

News Conference News ACC 2017

Radiation Exposure Greater for Radial vs Femoral PCI, RAD-MATRIX Dosimeter Study Confirms

L.A. McKeown

March 19, 2017

Presentation TCT 2016

MATRIX Critique: Pros and Cons

Presenter: Sunil V. Rao, Harvey D. White, Frederick Feit

October 31, 2016

Presentation TCT 2016

Trial #2 - The Essentials of ... the MATRIX Trial Access Site and Anticoagulation Type (And Infusion Duration) in ACS

Presenter: Sunil V. Rao, Harvey D. White, Salvatore Brugaletta

October 31, 2016

News Conference News TCT 2016

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Yael L. Maxwell

October 31, 2016

Advertisement

Two-year data shows trend towards lower target vessel failure with Indian stent Supraflex vs. Xience stent from Abbott

SMT Announces CE* Mark for the Most Deliverable Stent Supraflex Cruz

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

Femoral Operators Get Bad Rap in Observational Studies, HEAT-PPCI Suggests

The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX

MATRIX: 1-Year Results Confirm Superiority of Transradial PCI

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

Radial Access PCI Reduces Risk of Mortality and Bleeding in VALIDATE-SWEDEHEART

Higher Bleeding Risks, Radial Advantages Confirmed in Women With ACS Undergoing PCI: MATRIX Subanalysis

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Radial Approach and Renal Protection: A MATRIX Trial Analysis

Latest Bivalirudin, Heparin Face-off in MI Cements Winner in Routine Practice: VALIDATE-SWEDEHEART

Valve, Heal Thyself: Pioneers Seek Tissue-Engineered Fix for Faulty, Failing Cardiac Parts

Large US Study Suggests Little Difference Between Bivalirudin and Heparin for Transradial Primary PCI

Transradial PCI in ACS Reduces Risk of Acute Kidney Injury

Radiation Exposure Greater for Radial vs Femoral PCI, RAD-MATRIX Dosimeter Study Confirms

MATRIX Critique: Pros and Cons

Trial #2 - The Essentials of ... the MATRIX Trial Access Site and Anticoagulation Type (And Infusion Duration) in ACS

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content